Summary: A new review finds that OSA contributes to memory decline through mechanisms like intermittent hypoxia and sleep fragmentation, which trigger neuroinflammation, neuronal injury, and synaptic dysfunction; while CPAP offers some protection, the authors call for better diagnostics and individualized treatment strategies.
Key Takeaways:
- OSA is linked to memory decline, especially in visual and verbal working memory.
- Intermittent hypoxia and sleep fragmentation drive brain changes through neuroinflammation, oxidative stress, and synaptic dysfunction.
- Severity and duration of OSA, including metrics like the oxygen desaturation index, correlate with memory impairment.
- Future research should explore gut microbiota, genetic, and epigenetic influences on OSA-related memory dysfunction.
Obstructive sleep apnea (OSA), commonly associated with cardiovascular and metabolic diseases, also plays a significant but less recognized role in memory decline, according to a new review published in Sleep Medicine Reviews.
Researchers from the Marshall University Joan C. Edwards School of Medicine and Shanghai Jiao Tong University School of Medicine reviewed evidence from human and animal studies showing that OSA patients often experience notable memory impairments, particularly in visual and verbal working memory. They report that key features of OSA—intermittent hypoxia and sleep fragmentation—trigger biological processes such as neuroinflammation, oxidative stress, neuronal injury, altered synaptic plasticity, and blood-brain barrier dysfunction, all of which contribute to cognitive decline.
Disease severity and duration are strongly linked to poorer memory performance, with measures like the oxygen desaturation index (ODI) correlating with the extent of impairment.
While CPAP therapy remains the most effective treatment for protecting cognitive function, the authors stress the need for additional therapies and more precise diagnostic tools to identify and manage OSA-related memory dysfunction. Early changes observed through brain imaging, EEG, and blood biomarkers may serve as emerging predictors of cognitive decline.
The authors also highlight future research directions, including the role of gut microbiota, genetic factors, and epigenetic changes in OSA-related memory decline.
They suggest that multidimensional clinical profiling could support the development of personalized treatment strategies.
We recommend for you:
ID 130775254 © Bulat Silvia | Dreamstime.com
